trimethoprim has been researched along with Kidney Neoplasms in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Kidney Neoplasms: Tumors or cancers of the KIDNEY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friesen, A | 1 |
| Hofstetter, A | 1 |
| Takacs, F | 1 |
1 other study available for trimethoprim and Kidney Neoplasms
| Article | Year |
|---|---|
[Plasma and renal tissue - concentrations of sulfametrol-trimethoprim following parenteral administration].
Topics: Adult; Drug Combinations; Female; Humans; Infusions, Parenteral; Kidney; Kidney Neoplasms; Male; Sul | 1983 |